Conjugate Vaccine Market is poised to value over CAGR of over 12.5% during the forecast period 2022 to 2028.

Conjugate denotes a connection or joining. Conjugate vaccines combine a weaker component, often a carrier protein or antigen, with a specific component of the germ to produce an extremely potent immune response that is specifically directed at essential components of the virus or bacteria. The protection of newborns and toddlers, longer-lasting immunity, their impact on bacterial carriage, and the development of herd immunity are some benefits of conjugate vaccines. The pneumococcus, also known as Streptococcus pneumoniae, is the bacterium that causes pneumococcal illness. It can result in infections of the blood, brain, and lungs. Children with pneumococcal illness typically have health issues before the age of 5. These include ear infections, blood infections, and meningitis. Both adults and children can get the sickness prevented by the vaccine. The pneumococcal conjugate vaccine is one of the two Pneumococcal illness vaccines that are now available. The market is expanding primarily due to technological improvements, rising regulatory approvals for conjugate vaccines, rising prevalence of diseases brought on by bacteria including Streptococcus pneumoniae and Neisseria meningitidis, and increased usage of conjugate vaccinations for adults. Contrarily, limited vaccination accessibility in distant locations and the difficult conjugate vaccine production process limit market expansion. As a result, numerous top vaccine producers are engaged in research and development for the creation of vaccinations. The need for PCV vaccines is increasing since pneumonia is a serious problem in many nations. It is anticipated that rising rates of infectious diseases including typhoid, pneumonia, and other ones will fuel the rise of conjugate vaccines globally.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Conjugate Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Conjugate Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Conjugate Vaccine Market:
• Bharat Biotech
• Biological E
• GlaxoSmithKline, plc
• Merck and Company
• Novartis AG
• Pfizer, Inc
• Sanofi Pasteur
• Serum Institute of India.
• Astellas Pharma Inc.
 Mitsubishi Tanabe Pharma Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

Conjugate Vaccine Market Segmentation:
By Type
• Monovalent Conjugate Vaccines
• Multivalent Conjugate Vaccines

By Disease Indication
• Pneumococcal
• Influenza
• Diptheria tetanus Pertussis
• Meningococcal
• Others

By Pathogen Type
• Bacterial Conjugate Vaccine
• Viral Conjugate Vaccine
• Combination (Viral and Bacterial) Conjugate Vaccine

By Patient Stage
• Pediatrics Conjugate Vaccine
• Adults Conjugate Vaccine

By Region
• North America
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Conjugate Vaccine Market By Type, By Disease Indication, By Pathogen Type, By Patient Stage and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics